08 Jul 2014, BioSpectrum Bureau , BioSpectrum
Taiwan has a 3 percent share in the bioscience market of the Asia-Pacific region.
The top three companies in Taiwan during 2013 were Grape King, Excelsior Medical, and St. Shine Optical.
Most of the companies in the Top 10 list are in the $100-200 million range.
A few key developments in Taiwan include:
Taiwan based TaiGen Biotechnology collaborated with Russian firm R-Pharm to develop and commercial- ize nemonoxacin (Taigexyn), a novel antibiotic for the treatment of bacterial infections.
Taiwan's Ministry of Health and Welfare ordered removal of 33 drugs prescribed for asthma, hypertension, ulcers from shelves on safety issues.
GE Healthcare installed FlexFactory biomanufacturing platform in Taiwan.
Taiwan based Genovate Biotechnology and ScinoPharm jointly developed oral generic drug Livepro (Entecavir), representing a new generation of drugs for the treatment of Hepatitis B
Scientists at the National Health Research Institute discovered genetic markers that can predict the likelihood of surviving pancreatic cancer.
TAIWAN: TOP 20 BIOSCIENCE COMPANIES